The U.S. Army yesterday issued a new Field Manual on “Sensitive Site Operations” (FM 3-90.15, 25 April 2007).
The document itself is restricted and the Army would not immediately provide a copy to Secrecy News. But a few blanks can nevertheless be filled in.
“A sensitive site is a designated, geographically limited area with special military, diplomatic, economic, or information sensitivity for the United States,” according to the Army Field Manual (2-0) on Intelligence (pdf).
“This includes factories with technical data on enemy weapon systems, war crimes sites, critical hostile government facilities, areas suspected of containing persons of high rank in a hostile government or organization, terrorist money laundering, and document storage areas for secret police forces.”
“Sensitive site exploitation consists of a series of activities inside a sensitive site captured from an adversary.”
“These activities exploit personnel, documents, electronic data, and material captured at the site, while neutralizing any threat posed by the site or its contents. While the physical process of exploiting the sensitive site begins at the site itself, full exploitation may involve teams of experts located around the world.”
For further background and description of some fairly recent sensitive site operations, see a seminar paper entitled “The Strategic Implications of Sensitive Site Exploitation” (pdf) by Col. Thomas S. Vandal, National Defense University, 2003.
See also “Managing Sensitive Site Exploitation — Notes from Operation Iraqi Freedom” (pdf) by Major Pete Lofy, 2003.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.
The Federation of American Scientists supports the Senate version of the Fix Our Forests Act.
The Federation of American Scientists supports the National Security Commission on Emerging Biotechnology’s Final Report and the Recommendations contained within it.